Uptrend Under Pressure 100
Institutional selling is building — 8 distribution days in the last 25 sessions. Severe risk · 100/100 · 8 distribution days (SPY) Nov 04 Full briefing →
View
Simple research view

OSCR · Oscar Health, Inc.

$35.19 +8.58% Nov 04 close
Detected setup Pocket Pivot · Setup Score 65/100

Stand aside — setup invalidated

Setup score 65, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about OSCR

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$OSCR

Oscar Health, Inc.

Oscar Health, Inc. is a large-cap Managed Health Care company in the Health Services sector with a market cap of $10B.

Health Services Managed Health Care stock Stage 2 · Advancing Base 4+ Scan vol 2.6×
$35.19 latest close
Market Structure
Trend structure: range
Latest event: structure_shift (bearish)
Join to Watchlist $OSCR Share card
Historical record

No newer session has been stored for $OSCR. Every level, score and criterion below is computed from the Nov 04 close session (1 session old), and may no longer hold.

Historical verdict · setup score 65/100 · data Nov 04 close · 1 session old

Stand aside — setup invalidated

Setup score 65, but distribution days reach 5 or more — stand aside until the condition resets.

Review six verdicts Inspect chart
Recent price action · daily
$30.00$35.00AugSepOctNov$35.19

What would change this verdict

What needs to turn for this to become buyable — the top failing checks across the legend council:

  • Minervini 2. Quarterly EPS growth ≥ 25% — -46.9% QoQ
  • O'Neil C: Quarterly EPS acceleration ≥ 25% — -46.9% QoQ
  • O'Neil S: Base tightness (ATR% ≤ 4.5%) — ATR% 4.90%
  • Zanger Named Zanger pattern only — Pocket Pivot is not one of Zanger's six
  • Zweig EPS growth above the market (≥15% QoQ) — -46.9% QoQ — Zweig wants growth above the S&P average
  • Zweig Insider buying — No insider buying flagged
Minority view — the council disagrees here
  • Minervini: watch Trend-template read: 12/13 pass; wait for the soft misses to improve.
  • O'Neil: avoid CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
  • Weinstein: buyable Stage-analysis read: Stage 2 with 7/7 measured criteria passing.
73 Strong
Legend Score · rates the stock Strong (73/100) — held back by eps growth

Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.

  • Relative Strength (25%) 100
  • Trend Template (25%) 100
  • Institutional Footprint (20%) 61
  • EPS Growth (15%) 30
  • Quality (SMR-like) (15%) 45

RS rank 99: top 1% of all stocks — true leadership. Trend template 8/8: price above rising 50/150/200-day lines — textbook uptrend structure. Institutional score 61: mild accumulation. EPS growth reads -0%, but trailing earnings are negative — that percentage is an artifact, capped. Quality 45: weak fundamentals (sales growth 30, return on equity 42, leverage 100). Updated 2026-11-05.

Earnings

Post-earnings setup

Next earnings Thursday, November 5, 2026 Before market open Exact clock time not supplied by source

Deterministic evidence

OSCR+8.58%
Sector proxy · XLV+3.06%
Broad market · SPY+1.65%
Same completed session window ending 2026-11-04. OSCR was +5.52 points vs XLV. +6.93 points vs SPY.
CatalystUnavailable Stock reactionPositive Sector reactionSupportive Opening surge— Event riskEarnings-driven

Session internals Mixed

Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.

Vs prior close+8.58% From the open-1.23% Range position67% GapFaded
QQQ confirmationConfirming (+0.97%) SMH confirmationDiverging (-2.75%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $35.19 +8.6% Nov 04 close
52W High $36.16 2.7% below high
Wks Since High 0w
RS Rank 98 percentile of scan
SMA 50 $31.79
Avg Vol 5,136,241
Rel Vol (Nov 04) 2.63× 1.18× on up days
More stats
52W Low $10.69
Tight Wks 0
Base B4
SMA 200 $23.84
RS Line vs High +0.0%
RS Line Slope +7.3% ▲
Group Rank #11/59
ADR% 4.7%
ATR(14) $1.72 (4.9%)
Vol Pace (live) N/A
A/D Days 17A / 16D
A/D Rating B
VDU Bars 0/10 d
Power Trend 2d
Earnings TODAY
Position in 52-week range 96thpercentile of the 52-week range
$10.69low
$36.16high

OSCR Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for OSCR.

Create Free Account

Technical Analysis Report Card

$OSCR · $35.19 · as of 2026-11-04 · multi-factor read
100
/ 100
Technicals 100/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$31.79 ↑
100-day$30.94 ↑
200-day$23.84 ↑
Bullish (50 > 200)

RSI (14)

Reading64.2 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateBullish
Histogram+0.097

Bullish — MACD above its signal line and above zero. Histogram expanding.

Bollinger Bands (20,2)

%B / Width96% · 17.7%

Near the upper band — buyers in control.

Volume · Buyer vs Seller

Up/Down vol1.18 · Neutral
Rel volume2.63×
Pocket pivots · 10d1
5d vs 50d vol117%
Heavy vol up / down1 / 0

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

  • Pocket pivot today — up-day volume beat every down day of the prior 10 sessions.
  • 1 heavy-volume up day vs 0 down in the last 20 sessions.

Support & Resistance

R · $36.1652-week high
Price · $35.19now
S · $29.08swing level
S · $28.30swing level
S · $27.86swing level

Fibonacci · Uptrend swing

23.6%$32.37
38.2%$30.02
50.0%$28.12
61.8%$26.23
78.6%$23.53

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for OSCR — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishRS 99 (leader)
Want this read in a legend's voice? Ask a Legend about OSCR
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (65/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.

Council consensus: 2 of 9 legends rate this Buyable · 5 watching.
Minervini Watch A Trend-template read: 12/13 pass; wait for the soft misses to improve.

partialEnter on break of $35.19 pivot with stop at $32.61 (risk 7.3%). SEPA Grade B (5/7).

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $35.19, MA150 $27.32, MA200 $23.84
1.2 150-day MA > 200-day MAMA150 $27.32 vs MA200 $23.84
Failing evidence
2. Quarterly EPS growth ≥ 25%-46.9% QoQ
12/13 checks
Method → Playbook → Ask →
O'Neil Avoid D CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

partialRule check says AVOID (4/8 checks passed) — CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 99
A: Annual earnings & revenue qualityRev +27.5% | ROE 38.5%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%-46.9% QoQ
S: Base tightness (ATR% ≤ 4.5%)ATR% 4.90%
4/8 checks
Method → Playbook → Ask →
Weinstein Buyable A Stage-analysis read: Stage 2 with 7/7 measured criteria passing.

highClassic Stage 2 advancing phase — strong weekly trend confirms uptrend. This is Weinstein's sweet spot: buy and hold while price remains above the 30-week MA.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $35.19 vs MA200 $23.84
Failing evidence
No failing criteria.
7/7 checks
Method → Playbook → Ask →
dennis Buyable A Turtle read: S1 breakout fired. The system buys the signal, stops 2N away, and adds at 0.5N intervals.
Passing evidence
No breakdown below the 20-day channel20-day low $29.62
Volatility-unit sizing (1N ≈ 1% of equity)1N = $1.68 (4.79% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
No failing criteria.
8/8 checks
Method → Playbook → Ask →
zanger Avoid B Zanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.
Passing evidence
Not extended (≤5% above the breakout point)Measured as passing
Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $40.47-$42.23; trail the rest
Failing evidence
Named Zanger pattern onlyPocket Pivot is not one of Zanger's six
5/6 checks
Method → Playbook → Ask →
zweig Watch D Zweig read: part of his screen passes but not all: EPS growth above the market (≥15% QoQ); Insider buying — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 18.3x — no PEG or forward P/E stored
Price strength (RS ≥ 70)RS score 99 — Zweig buys strength, not bargains
Failing evidence
EPS growth above the market (≥15% QoQ)-46.9% QoQ — Zweig wants growth above the S&P average
Insider buyingNo insider buying flagged
4/8 checks
Method → Playbook → Ask →
Livermore Watch B Pivotal-point read: 5/6 structural checks pass; awaiting volume confirmation.
Passing evidence
Price$35.19
Relative strengthRS 99
Failing evidence
Pivotal point cleared on expanding volumeNot confirmed
5/6 checks
Method → Playbook → Ask →
Darvas Watch B Box-theory read: 5/6 structural checks pass; awaiting volume confirmation.

mediumStock is at the top of its box — Darvas would wait for a decisive breakout on volume.

Passing evidence
Price$35.19
Relative strengthRS 99
Failing evidence
Box top broken on heavy volumeNot confirmed
5/6 checks
Method → Playbook → Ask →
Wyckoff Watch B Supply-and-demand read: 5/6 structural checks pass; awaiting volume confirmation.
Passing evidence
Price$35.19
Relative strengthRS 99
Failing evidence
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
5/6 checks
Method → Playbook → Ask →
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Base & Breakout Tracking
RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH NH
NH183RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +1 B
A: 15 D: 14 Net: +165 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 5/7 met
B 5/7 criteria
Separate score from the Minervini Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✗ EPS acceleration ≥25% QoQ -47%
✓ Revenue growth ≥20% YoY +28%
✗ Gross margin ≥30% —
✓ ROE ≥17% 39%
✓ RS rating ≥80 (leadership) 99
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -2.7%

Method Playbook

Trade it like O'Neil EXACT LEVELS · PRO
O'Neil D · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.
Pivot
Pro level
Published-method rule: Use the proper base pivot or handle high after CANSLIM leadership and market-direction checks are satisfied.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a breakout through the pivot on volume at least 40% above average; the valid buy zone ends 5% above the pivot.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Use the setup's structural stop with a hard 7–8% maximum-loss ceiling from the actual entry.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Protect progress under constructive support such as the 21-day or 10-week line; a stop may ratchet higher but never lower.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on the hard loss limit, a decisive support break, or a rule-based climax/distribution signal; a normal 20–25% advance is reviewed rather than assumed permanent.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

Pocket Pivot Historical replay: +20% before −8% within 40 sessions: 16% (n=679) · source bars 2024-11-01–2026-11-04 · avg +0.7% per setup (+0.09R) ⚠ Late-stage base (#4) ⚠ Negative earnings (CANSLIM C fail)
65 setup score
RS Score 99
Trend template 8/8 ✓
CANSLIM 77.5* (B)
volume ratio: 2.61 near moving avg: ✓ upper close: ✓ shooting star: ✗ price past buy range: ✗ vol beats down: ✓ bars since signal: 0 signal close: 35.19 validation reason: valid pocket-pivot multi tf evaluated: ✓ multi tf reason: weekly trend template 7/8 confirmed + no fresh 13-week low
Why This Setup?
Pocket Pivot · schematic

Up vol 13,515,830 vs max down vol 5,178,479 (near MA), upper_close=yes, bars_ago=0 | Strong trend (8/8) | Top RS (99) | High-confidence pattern (100%) | Volume surging | RS at new high | RS Blue Dot | Stage 2 | Gap-up day (2.6× vol) | Readiness 78/100 (watch) | CANSLIM 77.5 (B) | ⚠ Late-stage base (#4); Negative earnings (CANSLIM C fail)

Ask a Legend ▾
Base Breakout ⚠ Volatility widening into breakout ⚠ Late-stage base (#4) ⚠ Negative earnings (CANSLIM C fail)
65 setup score
RS Score 99
Trend template 8/8 ✓
CANSLIM 77.7* (B)
resistance: 35.01 depth: 0.1917 breakout volume ratio: 2.617 sessions since breakout: 0 fresh breakout: ✓ price past buy range: ✗ validation reason: valid breakout multi tf evaluated: ✓ multi tf reason: weekly trend template 7/8 confirmed + no fresh 13-week low
Why This Setup?
Base Breakout · schematic

Broke above 35.01, bars_since=0, extended=no | Strong trend (8/8) | Top RS (99) | High-confidence pattern (90%) | Volume surging | RS at new high | RS Blue Dot | Stage 2 | Gap-up day (2.6× vol) | Readiness 79/100 (watch) | CANSLIM 77.7 (B) | ⚠ Volatility widening into breakout; Late-stage base (#4); Negative earnings (CANSLIM C fail)

Ask a Legend ▾
Ascending Triangle ⚠ Volatility widening into breakout ⚠ Extended past buy zone ⚠ Late-stage base (#4) ⚠ Negative earnings (CANSLIM C fail) ⚠ Not actionable yet
55 setup score
RS Score 99
Trend template 8/8 ✓
CANSLIM 74.5* (B)
high slope: 0.0221 low slope: 0.0803 triangle height: 0.58 depth: 0.0179 triangle volume ratio: 0.905 validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly trend template 7/8 confirmed + weekly coiling
Why This Setup?
Ascending Triangle · schematic

Flat resistance (slope=0.0221), rising lows (slope=0.0803) | Strong trend (8/8) | Top RS (99) | High-confidence pattern (80%) | Volume surging | RS at new high | RS Blue Dot | Stage 2 | Gap-up day (2.6× vol) | Readiness 63/100 (early) | CANSLIM 74.5 (B) | ⚠ Volatility widening into breakout; Extended past buy zone; Late-stage base (#4); Negative earnings (CANSLIM C fail); Not actionable yet

Ask a Legend ▾
The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

4/7 universals met
  • Clear of earnings — not met in 0 days — event risk
  • Asymmetric reward — partly met Partly met — levels are a Pro detail
  • Not chasing (in range) — partly met Pivot distance unknown
  • A relative-strength leader — met RS rank 98
  • In a confirmed uptrend — met Stage 2 · Trend template 8/8
  • Risk is defined — met Met — levels are a Pro detail
  • Volume confirms — met 2.6× average
Why these seven? → The Universal Edge

Minervini Trend Template

8/8 ✓

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $35.19 vs SMA150 $27.32 / SMA200 $23.84
SMA 150 above SMA 200 SMA150 $27.32 vs SMA200 $23.84
SMA 200 trending up Slope +1.66 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $31.79
Price above SMA 50 $35.19 vs SMA50 $31.79
30%+ above 52-week low +229.2% from $10.69
Within 25% of 52-week high -2.7% from $36.16
RS score above 70 RS 99

Fundamentals

52W Range
96%
Mkt Cap SEC
10.1B
EPS QoQ
-47%
Rev YoY
+28%
ROE
39%
D/E
0.44
EPS TTM
$-1.69
Insider
No Buy

Company

Company profile
Oscar Health, Inc.
OSCR · NYSE · Health Services · Managed Health Care
Track all markets on TradingView
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 77.5* CANSLIM * disqualified on C, M
C · Curr. EPS
20
A · Annual EPS
98
N · New Highs
100
S · Supply/Demand
80
L · Leader RS
99
I · Inst. Spons.
100
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
7/8
W. RS
100
W. Support
$17.81
W. Resist
$35.01
Weekly Structure

Scan History

17× streak
Oct 26: 55 (Cup (no handle))Nov 03: 55 (Ascending Triangle)Nov 04: 65 (Ascending Triangle)Nov 05: 65 (Pocket Pivot)65
Nov 05
Pocket Pivot ✓ Gate
65
Nov 04
Ascending Triangle ✓ Gate
65 0.0%
Nov 03
Ascending Triangle
55 +8.6%
Oct 26
Cup (no handle)
55 +13.2%

Latest News

Headlines for OSCR
Loading headlines…

Get the full picture on OSCR

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial